Skip to main content
    S

    Scilex Holding Company (SCLX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $0.64
    -0.61 (-48.64%)

    Market Cap: $8.79M

    Last updated: Nov 17, 2026 at 4:22 PM ET

    Scilex Holding Company (SCLX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Scilex Holding Company (SCLX) has a market cap of $8.79M and an enterprise value of $89.03M. It kept -1833.55% of revenue as net income over the last 12 months. Its net debt of $80.24M equals 912.50% of its market cap.

    Total Valuation

    Enterprise value is 912.50% above the market cap, as debt exceeds cash.

    Market Cap$8.79M
    Enterprise Value$89.03M
    Latest price (Nov 17, 2026)$0.64

    Key Dates

    The next earnings report is expected on Apr 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateApr 8, 2027 (expected)
    Last Earnings DateAug 14, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.01% in the quarter ended Jun 30, 2026 and grew 18.59% a year over 2 years.

    Shares Outstanding6.89M
    Shares Change (YoY)-40.56%
    Shares Change (QoQ)+0.01%
    Share Count Growth (2Y CAGR)+18.59%

    Price Statistics

    The stock is down 94.17% over 52 weeks and trades 80.12% below its 50-day average.

    Beta (1Y)1.41
    52-Week Change-94.17%
    1-Month Change-75.02%
    3-Month Change-88.64%
    6-Month Change-82.76%
    5-Year Change-99.15%
    Total Return (1Y)-94.17%
    Total Return (3Y CAGR)-69.80%
    Total Return (5Y CAGR)-68.89%
    Max Drawdown (1Y)-95.42%
    Max Drawdown (3Y)-98.78%
    Sharpe Ratio (1Y)-2.39
    Correlation with SPY (1Y)0.17
    50-Day Average$3.22
    200-Day Average$5.03
    52-Week Range$1.24 to $16.81
    RSI (14 Days)7.8
    Average Volume (20 Days)73.09K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 0.07x current liabilities.

    Current Ratio0.07x
    Quick Ratio0.06x
    Interest Coverage-17.57x

    Returns and Efficiency

    Return on invested capital is 143.52% over the last 12 months, against a 5-year average of 131.84%.

    Return on Assets (ROA)-228.56%
    Return on Invested Capital (ROIC)143.52%
    ROA (5Y Average)-86.83%
    ROIC (5Y Average)131.84%
    Asset Turnover0.19x
    Inventory Turnover3.23x
    Receivables Turnover1.14x
    Cash Conversion Cycle-2455 days

    Scores

    SCLX has an Altman Z-Score of -13.46, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Altman Z-Score-13.46
    Altman Z ZoneDistress
    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $31.61M over the last 12 months is down 28.55% from the 12 months before.

    Revenue$31.61M
    Revenue Growth (YoY)-28.55%
    Gross Profit$17.54M
    Operating Income-$359.19M
    Pretax Income-$464.55M
    Net Income-$579.55M
    EBIT-$413.33M
    Reported EPS (TTM)-$40.28

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Cash and Equivalents$566.00K
    Total Debt$80.81M
    Net Debt$80.24M
    Net Debt Per Share$11.64
    Working Capital-$476.01M
    Shareholder Equity-$308.32M
    Tangible Book Value-$379.41M
    Total Assets$253.56M
    Total Liabilities$564.05M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$17.09M
    FCF Per Share-$2.92
    Depreciation and Amortization$10.74M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -1136.40%.

    Gross Margin55.50%
    Operating Margin-1136.40%
    Pretax Margin-1469.71%
    Net Margin-1833.55%
    EBIT Margin-1307.68%
    Gross Margin (5Y Average)72.39%

    Growth

    Revenue fell 7.35% a year over 3 years.

    Revenue Growth (3Y CAGR)-7.35%
    Revenue Growth (5Y CAGR)+5.13%

    Revenue and profit by year

    Stock Splits

    The last forward split was on Jun 16, 2026.

    Last Split DateJun 16, 2026
    Split TypeForward split

    Peer Position

    Against 3 similar companies, SCLX has the lowest P/S and the highest ROIC.

    P/S Ratio0.1x vs 3.0x median
    ROIC143.52% vs -56.16% median
    Revenue Growth (Trailing 4 Quarters, YoY)-28.55% vs -100.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 149.92% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+149.92%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About SCLX

    What is SCLX's market cap?

    Scilex Holding Company has a market cap of $8.79M. Its enterprise value, which adds debt and subtracts cash, is $89.03M.

    How many shares of SCLX are outstanding?

    Scilex Holding Company has 6.89M shares outstanding. The count is down 40.56% from a year earlier.

    Does SCLX pay a dividend?

    No. Scilex Holding Company does not pay a dividend.

    How much debt does SCLX have?

    Scilex Holding Company has $80.81M of total debt and $566.00K of cash and equivalents, a net debt position of $80.24M.